Evidence mapPaperPMID 33567446Full record

ReviewInternational archives of allergy and immunology2021

Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19.

Jean Bousquet, Wienczyslawa Czarlewski, Torsten Zuberbier, Joaquim Mullol, Hubert Blain, Jean-Paul Cristol, Rafael De La Torre, Nieves Pizarro Lozano, Vincent Le Moing, Anna Bedbrook and 32 more

Open access · bronzeAbstract readReview
In one paragraph

Review in International archives of allergy and immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Antiviral and Immune Enhancement Effect ofMolecules (Basel, Switzerland) · 2025
    Review
  4. Review
  5. TRP Ion Channels in Immune Cells and Their Implications for Inflammation.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. TRPV1, Nrf2, and COVID-19: Could Oxytocin Have a Beneficial Role to Play?International archives of allergy and immunology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

42 authors at 20 institutions in 20 countries.

Jean BousquetDepartment of Dermatology and Allergy, Comprehensive Allergy Center, Charité, and Berlin Institute of Health, Comprehensive Allergy Center, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany, jean.bousquet@orange.fr.
Wienczyslawa CzarlewskiMedical Consulting Czarlewski, Levallois, France.
Torsten ZuberbierDepartment of Dermatology and Allergy, Comprehensive Allergy Center, Charité, and Berlin Institute of Health, Comprehensive Allergy Center, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Joaquim MullolRhinology Unit & Smell Clinic, ENT Department, Hospital Clinic - Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, Universitat de Barcelona, Barcelona, Spain.
Hubert BlainDepartment of Geriatrics, Montpellier University Hospital, Montpellier, France.
Jean-Paul CristolLaboratoire de Biochimie et Hormonologie, PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU de, Montpellier, France.
Rafael De La TorreCIBER Fisiopatologia de la Obesidad y Nutrición (CIBEROBN), Madrid, Spain.
Nieves Pizarro LozanoIMIM (Hospital del Mar Research Institute), Barcelona, Spain.
Vincent Le MoingMaladies Infectieuses et Tropicales, CHU, Montpellier, France.
Anna BedbrookUniversity Hospital and MACVIA France, Montpellier, France.
Ioana AgacheFaculty of Medicine, Transylvania University, Brasov, Romania.
Cezmi A AkdisChristine Kühne - Center for Allergy Research and Education (CK-CARE), Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Zurich, Switzerland.
G Walter CanonicaPersonalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center IRCCS and Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Alvaro A CruzFundação ProAR, Federal University of Bahia and GARD/WHO Planning Group, Salvador, Brazil.
Alessandro FiocchiDivision of Allergy, The Bambino Gesù Children's Research Hospital IRCCS, Rome, Italy.
Joao A FonsecaCINTESIS, Center for Research in Health Technologies and Information Systems, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
Susana FonsecaGreenUPorto - Sustainable Agrifood Production Research Centre, DGAOT, Faculty of Sciences, University of Porto, Vila do Conde, Portugal.
Bilun GemicioğluDepartment of Pulmonary Diseases, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Turkey.
Tari HaahtelaSkin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.
Guido IaccarinoInterdepartmental Center of Research on Hypertension and Related Conditions CIRIAPA, Federico II University, Napoli, Italy.
Juan Carlos IvancevichServicio de Alergia e Immunologia, Clinica Santa Isabel, Buenos Aires, Argentina.
Marek JutelDepartment of Clinical Immunology, Wrocław Medical University and ALL-MED Medical Research Institute, Wrocław, Poland.
Ludger KlimekCenter for Rhinology and Allergology, Wiesbaden, Germany.
Helga KraxnerDepartment of Otorhinolaryngology, Head and Neck Surgery, Semmelweis University, Budapest, Hungary.
Piotr KunaDivision of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
Désirée E Larenas-LinnemannCenter of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, Mexico City, Mexico.
Adrian MartineauInstitute for Population Health Sciences, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Erik MelénInstitute of Environmental Medicine, Karolinska Institutet and Sachs' Children's Hospital, Stockholm, Sweden.
Yoshitaka OkamotoDepartment of Otorhinolaryngology, Chiba University Hospital, Chiba, Japan.
Nikolaos G PapadopoulosDivision of Infection, Immunity & Respiratory Medicine, Royal Manchester Children's Hospital, University of Manchester, Manchester, United Kingdom.
Oliver PfaarSection of Rhinology and Allergy, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
Frederico S RegateiroAllergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, Faculty of Medicine, Institute of Immunology, University of Coimbra, Coimbra, Portugal.
Jacques ReynesMaladies Infectieuses et Tropicales, CHU, Montpellier, France.
Yves RollandCHU Toulouse, Toulouse, France.
Philip W RouadiDepartment of Otolaryngology-Head and Neck Surgery, Eye and Ear University Hospital, Beirut, Lebanon.
Boleslaw SamolinskiDepartment of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
Aziz SheikhUsher Institute, The University of Edinburgh, Edinburgh, United Kingdom.
Sanna Toppila-SalmiSkin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.
Arunas ValiulisVilnius University Faculty of Medicine, Institute of Clinical Medicine & Institute of Health Sciences, Vilnius, Lithuania.
Hak-Jong ChoiResearch and Development Division, Microbiology and Functionality Research Group, World Institute of Kimchi, Gwangju, Republic of Korea.
Hyun Ju KimStrategy and Planning Division, SME Service Department, World Institute of Kimchi, Gwangju, Republic of Korea.
Josep M AntoIMIM (Hospital del Mar Research Institute), Barcelona, Spain.
Humboldt-Universität zu Berlin · DEUniversidade do Porto · PTUniversitat Pompeu Fabra · ESUniversity of Helsinki · FIWorld Institute of Kimchi · KRBambino Gesù Children's Hospital · ITCentre Hospitalier Universitaire de Montpellier · FRCentre Hospitalier Universitaire de Toulouse · FRCentre National de la Recherche Scientifique · FRChiba University Hospital · JPFederico II University Hospital · ITHospitais da Universidade de Coimbra · PTHospital Clínic de Barcelona · ESHospital Del Mar · ESHospital Médica Sur · MXHumanitas University · ITIstanbul University-Cerrahpaşa · TRKarolinska Institutet · SEMedical University of Lodz · PLMedical University of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this article, we propose that differences in COVID-19 morbidity may be associated with transient receptor potential ankyrin 1 (TRPA1) and/or transient receptor potential vanilloid 1 (TRPV1) activation as well as desensitization. TRPA1 and TRPV1 induce inflammation and play a key role in the physiology of almost all organs. They may augment sensory or vagal nerve discharges to evoke pain and several symptoms of COVID-19, including cough, nasal obstruction, vomiting, diarrhea, and, at least partly, sudden and severe loss of smell and taste. TRPA1 can be activated by reactive oxygen species and may therefore be up-regulated in COVID-19. TRPA1 and TRPV1 channels can be activated by pungent compounds including many nuclear factor (erythroid-derived 2) (Nrf2)-interacting foods leading to channel desensitization. Interactions between Nrf2-associated nutrients and TRPA1/TRPV1 may be partly responsible for the severity of some of the COVID-19 symptoms. The regulation by Nrf2 of TRPA1/TRPV1 is still unclear, but suggested from very limited clinical evidence. In COVID-19, it is proposed that rapid desensitization of TRAP1/TRPV1 by some ingredients in foods could reduce symptom severity and provide new therapeutic strategies.

Indexed as

AntioxidantsBiomarkersBrassicaCOVID-19COVID-19 TestingDesensitization, ImmunologicDown-RegulationHumansNF-E2-Related Factor 2NutrientsOxidative StressSARS-CoV-2Severity of Illness IndexTRPA1 Cation ChannelTRPV Cation ChannelsUp-RegulationAntioxidantsBiomarkersNFE2L2 protein, humanNF-E2-Related Factor 2NutrientsTRPA1 Cation ChannelTRPA1 protein, humanTRPV1 protein, humanTRPV Cation ChannelsBroccoliCough challengeCOVID-19Nrf2Pungent foodsTRAP-1

Identifiers

PMID33567446
PMCPMC8018185
OpenAlexW3126869267

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.